ConductScience.org, home

Paper23134

Assessment of combined oral theophylline and inhaled beta-adrenoceptor agonist bronchodilator therapy.

Marlin GE and 3 others. Br J Clin Pharmacol, 1978. Cited by 39 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Assessment of combined oral theophylline and inhaled beta-adrenoceptor agonist bronchodilator therapy. Papers, record 23134. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23134

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Assessment of combined oral theophylline and inhaled beta-adrenoceptor agonist bronchodilator therapy.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1978
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
39
iCite
Relative citation ratio, by iCite
2.52
iCite
Revised in PubMed
2019-05-09
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Marlin GEG E
2Hartnett BJB J
3Berend NN
4Hacket NBN B

Source PubMed

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Airway ObstructionMajor topic
Bronchodilator AgentsMajor topic
CatecholsMajor topic
PiperidinesMajor topic
TheophyllineMajor topic
Administration, Oral
Adult
Aerosols
Aged
Chronic Disease
Clinical Trials as Topic
Double-Blind Method
Drug Evaluation
Drug Therapy, Combination
Female
Humans
Male
Middle Aged

Source PubMed

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110,940Comparison of the beta2-adrenoceptor selectivity of rimiterol, salbutamol and isoprenaline by the intravenous route in man.Br J Clin Pharmacol1975https://conductscience.org/library/papers/10940PubMed
21,116,382Comparison between the bronchodilator and cardiovascular effects of inhaling 0.5 mg. rimiterol ('Pulmadil') and 0.2 mg. salbutamol.Curr Med Res Opin1975https://conductscience.org/library/papers/1116382PubMed
31,233,207Plasma level and broncholytic effect of choline theophyllinate after a single dose of a press-coated tablet formulation.Eur J Clin Pharmacol1975https://conductscience.org/library/papers/1233207PubMed
613,716,795The response to bronchodilators in intrinsic asthma.Q J Med1961https://conductscience.org/library/papers/13716795PubMed
714,058,168PATTERNS OF RESPONSE TO BRONCHODILATOR IN YOUNG PATIENTS WITH ASTHMA.Australas Ann Med1963https://conductscience.org/library/papers/14058168PubMed
814,114,639CLINICAL EVALUATION OF ELIXOPHYLLIN WITH CORRELATION OF PULMONARY FUNCTION STUDIES AND THEOPHYLLINE SERUM LEVELS IN ACUTE AND CHRONIC ASTHMATIC PATIENTS.Dis Chest1964https://conductscience.org/library/papers/14114639PubMed
9170,700Bronchodilator drug efficacy via cyclic AMP.Thorax1975https://conductscience.org/library/papers/170700PubMed
10240,780The relative potencies and beta2-selectivities of intravenous rimiterol, salbutamol and isoprenaline in asthmatic patients.Int J Clin Pharmacol Biopharm1975https://conductscience.org/library/papers/240780PubMed
114,108,129Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. II. Influence of cellular levels of cyclic AMP.Fed Proc1971https://conductscience.org/library/papers/4108129PubMed
124,147,213Clinical assessment of bronchodilator drugs delivered by aerosol.Thorax1973https://conductscience.org/library/papers/4147213PubMed
134,401,704A comparison of isoprenaline, salbutamol, and rimiterol inhalation on skin temperature, heart rate, and respiration in man.J Clin Pharmacol New Drugs1972https://conductscience.org/library/papers/4401704PubMed
144,404,808The effect of a new adrenergic beta 2 -receptor-stimulating agent (rimiterol, R798) in patients with chronic obstructive lung disease.Scand J Respir Dis1972https://conductscience.org/library/papers/4404808PubMed
154,412,772Determination of theophylline and its metabolites in human urine and serum by high-pressure liquid chromatography.J Lab Clin Med1974https://conductscience.org/library/papers/4412772PubMed
164,598,678Clinical trial of rapidly dissolving theophylline tablets.Med J Aust1974https://conductscience.org/library/papers/4598678PubMed
174,932,744Preliminary studies of a new bronchodilator (WG 253) in man.J Clin Pharmacol New Drugs1971https://conductscience.org/library/papers/4932744PubMed
185,026,376Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.Clin Pharmacol Ther1972https://conductscience.org/library/papers/5026376PubMed
194,720,690A re-evaluation of parenteral aminophylline.Am Rev Respir Dis1973https://conductscience.org/library/papers/4720690PubMed
204,723,589Rational intravenous doses of theophylline.N Engl J Med1973https://conductscience.org/library/papers/4723589PubMed

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.

PMIDTitleJournalYearIn PapersSource
25,786,880Concurrent oral and inhalation drug delivery using a dual formulation system: the use of oral theophylline carrier with combined inhalable budesonide and terbutaline.Drug Deliv Transl Res2014https://conductscience.org/library/papers/25786880PubMed
12,519,617Oral theophylline for chronic obstructive pulmonary disease.Cochrane Database Syst Rev2002https://conductscience.org/library/papers/12519617PubMed
7,437,244Serum level monitoring of a new slow release theophylline formulation in patients with chronic lung disease.Br J Clin Pharmacol1980https://conductscience.org/library/papers/7437244PubMed
7,378,251Combination of aminophylline (Phyllocontin Continus tablets) and salbutamol in the management of chronic obstructive airways disease.Br J Clin Pharmacol1980https://conductscience.org/library/papers/7378251PubMed
7,213,523Theophylline-salbutamol interaction: bronchodilator response to salbutamol at maximally effective plasma theophylline concentrations.Br J Clin Pharmacol1981https://conductscience.org/library/papers/7213523PubMed
7,117,350The influence of theophylline on maximal response to salbutamol in severe chronic obstructive pulmonary disease.Eur J Clin Pharmacol1982https://conductscience.org/library/papers/7117350PubMed
7,011,349The metabolic actions of intravenous salbutamol and aminophylline singly and in combination.Br J Clin Pharmacol1981https://conductscience.org/library/papers/7011349PubMed
6,129,123Combination bronchodilator therapy.Drugs1982https://conductscience.org/library/papers/6129123PubMed
3,081,769Tracheal relaxation from combinations of xanthines and of a beta 2-receptor agonist and xanthines.Lung1986https://conductscience.org/library/papers/3081769PubMed
533,582Dose-titration comparison of inhaled salbutamol and oral theophylline in asthma.Br J Clin Pharmacol1979https://conductscience.org/library/papers/533582PubMed
391,006On the action of combination bronchodilators.Agents Actions1979https://conductscience.org/library/papers/391006PubMed
354,635Clinical pharmacokinetics of theophylline.Clin Pharmacokinet1978https://conductscience.org/library/papers/354635PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23134

GET https://conductscience.org/api/papers/v1/23134/authors